Anúncio
Anúncio
BCYC
Bicycle Therapeutics plc - ADR
6.65
USDPatrocinado
+0.02
+0.29%
09 de jan., 15:59 UTC -5
Encerrado
Pós-Mercado
6.65
0.00
+0.02%
Relatórios de Lucros BCYC
Rácio de surpresa positiva
BCYC separação 12 de 26 últimas estimativas.
46%
Próximo Relatório
Data do Próximo Relatório
23 de fev. de 2026
Estimate for Q4 25 (Revenue/ EPS)
$7.22M
/-$0.95
Mudanças implicadas de Q3 25 (Revenue/ EPS)
-38.49%
/+11.76%
Mudanças implicadas de Q4 24 (Revenue/ EPS)
+94.65%
/+15.85%
Bicycle Therapeutics plc - ADR earnings per share and revenue
On 30 de out. de 2025, BCYC reported earnings of -0.85 USD per share (EPS) for Q3 25, beating the estimate of -1.09 USD, resulting in a 22.68% surprise. Revenue reached 11.73 milhão, compared to an expected 7.48 milhão, with a 56.88% difference. The market reacted with a +7.09% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 16 analistas forecast an EPS of -0.95 USD, with revenue projected to reach 7.22 milhão USD, implying an aumentar of 11.76% EPS, and diminuir of -38.49% in Revenue from the last quarter.
FAQ
What were Bicycle Therapeutics plc - ADR's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Bicycle Therapeutics plc - ADR reported EPS of -$0.85, beating estimates by 22.68%, and revenue of $11.73M, 56.88% above expectations.
How did the market react to Bicycle Therapeutics plc - ADR's Q3 2025 earnings?
The stock price moved up 7.09%, changed from $8.18 before the earnings release to $8.76 the day after.
When is Bicycle Therapeutics plc - ADR expected to report next?
The next earning report is scheduled for 23 de fev. de 2026.
What are the forecasts for Bicycle Therapeutics plc - ADR's next earnings report?
Based on 16
analistas, Bicycle Therapeutics plc - ADR is expected to report EPS of -$0.95 and revenue of $7.22M for Q4 2025.
Which companies are reporting earnings today?
Verificar FXEmpire's Earnings Calendar for today's list of reporting companies.
Anúncio